1. Home
  2. RGEN vs FUTU Comparison

RGEN vs FUTU Comparison

Compare RGEN & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FUTU
  • Stock Information
  • Founded
  • RGEN 1981
  • FUTU 2011
  • Country
  • RGEN United States
  • FUTU Hong Kong
  • Employees
  • RGEN N/A
  • FUTU N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FUTU Investment Bankers/Brokers/Service
  • Sector
  • RGEN Health Care
  • FUTU Finance
  • Exchange
  • RGEN Nasdaq
  • FUTU Nasdaq
  • Market Cap
  • RGEN 8.2B
  • FUTU 8.5B
  • IPO Year
  • RGEN N/A
  • FUTU 2019
  • Fundamental
  • Price
  • RGEN $145.78
  • FUTU $67.56
  • Analyst Decision
  • RGEN Buy
  • FUTU Strong Buy
  • Analyst Count
  • RGEN 10
  • FUTU 7
  • Target Price
  • RGEN $188.38
  • FUTU $71.57
  • AVG Volume (30 Days)
  • RGEN 815.6K
  • FUTU 1.2M
  • Earning Date
  • RGEN 10-29-2024
  • FUTU 08-20-2024
  • Dividend Yield
  • RGEN N/A
  • FUTU N/A
  • EPS Growth
  • RGEN N/A
  • FUTU 5.70
  • EPS
  • RGEN N/A
  • FUTU 3.86
  • Revenue
  • RGEN $602,354,000.00
  • FUTU $1,216,035,584.00
  • Revenue This Year
  • RGEN $0.08
  • FUTU $26.87
  • Revenue Next Year
  • RGEN $12.97
  • FUTU $11.31
  • P/E Ratio
  • RGEN N/A
  • FUTU $15.41
  • Revenue Growth
  • RGEN N/A
  • FUTU 9.98
  • 52 Week Low
  • RGEN $110.45
  • FUTU $43.61
  • 52 Week High
  • RGEN $211.13
  • FUTU $81.86
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 50.39
  • FUTU 48.44
  • Support Level
  • RGEN $135.88
  • FUTU $56.22
  • Resistance Level
  • RGEN $150.72
  • FUTU $61.10
  • Average True Range (ATR)
  • RGEN 5.37
  • FUTU 1.69
  • MACD
  • RGEN -0.37
  • FUTU 0.02
  • Stochastic Oscillator
  • RGEN 58.10
  • FUTU 41.96

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Share on Social Networks: